AAREYDRUGS
Start SIP
Invest Now
Start SIP in AAREYDRUGS
Performance
- Low
- ₹65
- High
- ₹69
- 52 Week Low
- ₹31
- 52 Week High
- ₹100
- Open Price₹65
- Previous Close₹66
- Volume257,600
- 50 DMA₹72.09
- 100 DMA₹73.67
- 200 DMA₹70.02
Investment Returns
- Over 1 Month -4.88%
- Over 3 Month -21.85%
- Over 6 Month + 2.53%
- Over 1 Year + 41.65%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 54.4
- PEG Ratio
- -1.3
- Market Cap Cr
- 195
- P/B Ratio
- 1.3
- Average True Range
- 3.48
- EPS
- 1.26
- Dividend Yield
- 0
- MACD Signal
- -2.84
- RSI
- 50.85
- MFI
- 65.91
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹68.77
+
3.24
(4.94%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹67.12
- 50 Day
- ₹72.09
- 100 Day
- ₹73.67
- 200 Day
- ₹70.02
Resistance and Support
67.61
- R3 73.51
- R2 71.16
- R1 69.96
- S1 66.41
- S2 64.06
- S3 62.86
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-04 | To consider Fund Raising |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹68 As on 26 January, 2026 | 05:42
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹195 Cr As on 26 January, 2026 | 05:42
The P/E ratio of Aarey Drugs & Pharmaceuticals is 54.4 As on 26 January, 2026 | 05:42
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.3 As on 26 January, 2026 | 05:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.